Form 4 for HURA TuHURA Biosciences, Inc./NV
Accepted 2023-06-02 00:00:00 ET · period of report 2023-06-01 · accession 0001493152-23-019950 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-02 | 2023-06-01 | HURA | Hoffman Robert E. | Pres, CEO, CFO, Dir | A - Grant | $0.00 | +59.8K | 68.9K | +657% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2023-06-01 | A | A | 59,800 | $0.00 | 68,902 | D | — | — | (F1) The Reporting Person was granted 59,800 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in full on June 1, 2024. |